UCB announces approval of Bimzelx
31st August 2023 Uncategorised 0The therapy is used to treat patients with psoriatic arthritis and axial spondyloarthritis
More: UCB announces approval of Bimzelx
Source: News
The therapy is used to treat patients with psoriatic arthritis and axial spondyloarthritis
More: UCB announces approval of Bimzelx
Source: News
© 1994 - 2024 B.M. Pharmaceuticals